ArticleFederal practitioner : for the health care professionals of the VA, DoD, and PHS2025
Anticoagulation Stewardship Efforts Via Indication Reviews at a Veterans Affairs Health Care System.
Article in Federal practitioner : for the health care professionals of the VA, DoD, and PHS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Anticoagulation is an important pharmacologic intervention used to prevent thrombotic complications in patients with atrial fibrillation (Afib), and for prophylaxis or treatment of venous thromboembolism (VTE). Inappropriate use of anticoagulant medications can lead to significant adverse drug events. This quality improvement study implemented pharmacist-led anticoagulation stewardship at the Veterans Affairs Phoenix Health Care System (VAPHCS) to identify patients with Afib not currently on anticoagulation and those with a history of VTE events who had completed sufficient treatment. Methods: Charts for individuals with a documented Afib or atrial flutter without an active prescription for anticoagulants were reviewed and a standardized note template was used to document recommendations. Veterans with a documented VTE event and an active prescription for anticoagulants written between November 2022 and November 2023 were identified. The primary outcomes were the number of veterans with Afib recommended to start anticoagulation therapy and the number of veterans with a history of VTE events recommended to discontinue anticoagulation therapy. Results: A total of 114 patients (57 with Afib and 57 with VTE) were included. Seven recommendations were made to clinicians for patients with Afib, and 1 veteran was successfully started on anticoagulation therapy. Seven recommendations were made to clinicians for patients with VTE. Conclusions: This quality improvement study identified gaps in care related to anticoagulation needs in the VAPHCS veteran population. Using a standardized indication review process allows pharmacists to evaluate anticoagulant use for both appropriate indication and duration of therapy. Providing recommendations via chart review notes and alerting clinicians may ensure that veterans receive safe, effective, and optimized anticoagulation care.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.